Explore the complete record of transactions filed by 김운장, Président Honoraire. Officer active across 1 companies, notably 대화제약. Aggregated, 5 disclosures have been published. The latest transaction was disclosed on 27 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Kim Un-jang is the Honorary Chairman of 대화제약, where he contributes to the strategic direction of the company. Although there are no detailed insights into his specific functions, his role is crucial for the smooth operation and growth of 대화제약.